- Buttram, M. E., Ellis, M. S., & Stivers, Y. (2023). Law Enforcement Experiences with Gabapentin: Non-medical Use, Diversion, and State Controlled Substances Laws. Journal of Substance Use. DOI: https://doi.org/10.1080/14659891.2023.2239360.
- Buttram, M. E., Kurtz, S. P., Margolin, Z. R., & Severtson, S. G. (2021). Increasing rates of buprenorphine diversion in the United States, 2002 to 2019. Pharmacoepidemiology and drug safety, 30(11), 1514-1519.
- Kurtz, S. P., Buttram, M. E., Margolin, Z. R., & Wogenstahl, K. (2019). The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017. Pharmacoepidemiology and drug safety, 28(5), 700-706.
- Buttram, M. E., Kurtz, S. P., Dart, R. C., & Margolin, Z. R. (2017). Law enforcement‐derived data on gabapentin diversion and misuse, 2002‐2015: diversion rates and qualitative research findings. Pharmacoepidemiology and drug safety, 26(9), 1083-1086.
- Iwanicki, J. L., Severtson, S. G., McDaniel, H., Rosenblum, A., Fong, C., Cicero, T. J., … & Dart, R. C. (2016). Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States. PloS one, 11(12), e0167499.
- Severtson, S. G., Ellis, M. S., Kurtz, S. P., Rosenblum, A., Cicero, T. J., Parrino, M. W., … & Dart, R. C. (2016). Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and alcohol dependence, 168, 219-229.
Dart, R. C., Surratt, H. L., Le Lait, M. C., Stivers, Y., Bebarta, V. S., Freifeld, C. C., … & Dasgupta, N. (2016). Diversion and illicit sale of extended release tapentadol in the United States. Pain medicine, 17(8), 1490-1496.
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241-248.
Surratt, H. L., O’grady, C., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., & Chen, M. (2014). Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiology and drug safety, 23(3), 314-320.